About this Event
Join the UCSF-JHU Opioid Industry Documents Archive on Thursday, October 9 at 10 am PT (1:00 pm ET / 12:00 pm CT) as we host a Q&A with Dr. Christopher K. Haddock and Dr. Andrew Kolodny about their research team's recently published article, "Imagine the Possibilities Pain Coalition and Opioid Marketing to Veterans: Lessons for Military and Veterans Healthcare."
-
Christopher K. Haddock, Ph.D., holds key leadership roles as the Chief Scientific Officer for the National Development and Research Institutes (NDRI-USA) and as President and Chief Data and Analytics Officer for the Social Sciences Innovations Corporation (SSIC) with offices in New York, NY, and Leawood, KS. Since 2008, he has also been a co-owner and senior consultant at the HOPE Health Research Institute, LLC. His expertise is further enhanced by postdoctoral fellowships in Clinical Health Psychology with the U.S. Air Force and in Cardiovascular Health with the American Hospital Association’s Health Forum. A decorated military veteran who served on active duty and as an active Reserve officer in the U.S. Air Force, his military background informs his research on populations such as first responders and veterans.
- Dr. Andrew Kolodny is the Medical Director of the Opioid Policy Research Collaborative at Brandeis University and serves as President of Physicians for Responsible Opioid Prescribing. He has played a key role in investigations of the opioid industry conducted by U.S. Congressional Committees, the Department of Justice, and state Attorneys General. Dr. Kolodny has served as an expert witness in litigation brought by state governments against opioid manufacturers and was the medical advisor for the Hulu series Dopesick. Earlier in his career, he was Chair of Psychiatry at Maimonides Medical Center in New York City.
-
Moderator: Dan Kabella, Ph.D., received a doctorate in Human and Social Dimensions of Science and Technology from Arizona State University’s School for the Future of Innovation. Kabella is a Postdoctoral Fellow with the Opioid Industry Documents Archive (OIDA) at the University of California, San Francisco’s Center for Tobacco Control Research and Education. Kabella’s research focuses on the opioid industry’s corporate capture of digital health infrastructure and the use of technologies in shaping regulatory and public health practices.
UCSF promotes the exchange of diverse ideas and perspectives, acknowledging that the views and opinions of our guest speakers on campus are their own and may not reflect the perspective of the University. We embrace free speech in the pursuit of greater understanding, consistent with our obligations as a public university under the First Amendment.